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Abstract
The Paf complex of Opisthokonts and plants contains at least five subunits: Paf1, Cdc73, Rtf1, Ctr9, and Leo1. Mutations in,
or loss of Paf complex subunits have been shown to cause defects in histone modification, mRNA polyadenylation, and
transcription by RNA polymerase I and RNA polymerase II. We here investigated trypanosome CTR9, which is essential for
trypanosome survival. The results of tandem affinity purification suggested that trypanosome CTR9 associates with
homologues of Leo1 and Cdc73; genes encoding homologues of Rtf1 and Paf1 were not found. RNAi targeting CTR9
resulted in at least ten-fold decreases in 131 essential mRNAs: they included several that are required for gene expression
and its control, such as those encoding subunits of RNA polymerases, exoribonucleases that target mRNA, RNA helicases
and RNA-binding proteins. Simultaneously, some genes from regions subject to chromatin silencing were derepressed,
possibly as a secondary effect of the loss of two proteins that are required for silencing, ISWI and NLP1.
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Introduction
The Paf complex has been implicated in several different aspects
of gene expression within the nuclei of yeast and mammalian cells
(Opisthokonts) and plants: defects have been shown to influence
transcriptional elongation and termination, mRNA processing and
export, and to result in epigenetic changes [1]. In Saccharomyces
cerevisiae, the Paf complex consists of five subunits: Paf1, Cdc73,
Rtf1, Ctr9, and Leo1; the human complex also contains Ski8 [1].
The complex is not essential in yeast: but although individual
deletions of each subunit are viable, deletions of either PAF1 or
CTR9 caused decreases in at least 300, and increases in over 900
mRNAs; over half of these were affected in similar ways by both
deletions [2]. In contrast, mutation of the human homologues of
Cdc73 (HRPT2/CDC73 or parathrombin), loss of Ctr9, and over-
expression of Paf1 have all been associated with cancer [1], and a
parathrombin missense mutant both impaired nucleolar localiza-
tion and promoted growth and survival of NIH3T3 cells [3]. In
zebrafish, mutation in Rtf1 or Leo1 led to developmental defects
[4,5], while in Arabidopisis, the complex is involved in transcrip-
tional control of flowering [6].
The complex has been shown to bind to RNA polymerase II;
mutations in either Cdc73 or Rtf1 abolished the binding and
resulted in reduced phosphorylation of the C-terminal domain or
the largest polymerase II subunit [7]. The complex also stimulates
elongation on chromatin substrates, and this effect was not
secondary to changes in histone modification [8]. By chromatin
IP, the complex was found throughout polymerase-II-transcribed
regions of the yeast genome, but association stopped upstream of
the polyadenylation site [9]. In both human cells and yeast, an
interaction of the Paf1 subunit with a MAP kinase blocked
transcription termination on specific genes [10].
Epigenetic changes associated with the Paf complex include
histone methylation, ubiquitylation and acetylation. The Rtf1
component is implicated in histone ubiquitylation [11,12], histone
[13] and DNA methylation [14]; but association of Rtf1 with the
rest of the complex may not always be required for its activity [13].
Meanwhile the human Cdc73 homologue parathrombin has been
shown to be required for very specific types of histone H3
methylation [15]; the complex was also shown to affect histone
acetylation in vitro [8].
Defects in transcription elongation can affect choices between
alternative polyadenylation and splice sites [16,17,18,19]. One
possible reason is that there are effects on pre-RNA secondary
structure; a second possibility is that if polymerase pauses after
synthesis of one, rather inefficient, processing site, there may be
time for that site to be used before an alternative, more efficient
downstream site has been synthesised. Thus although mutations in
the Paf complex can result in changes in mRNA processing, it is
not clear how many of the effects are direct. For example, yeast
Paf deletion mutants show changes in poly(A) site selection (e.g.
[2]); and the complex directly interacts with polyadenylation
factors [7,20]. In addition, Leo1 interacts directly with RNA in vitro
[21] and is necessary, and sufficient for association of the complex
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be RNA-mediated [21].
Very few studies have examined possible roles of the Paf1
complex in RNA polymerase I transcription. One found that
Paf1 was required for histone K4 methylation on the rDNA
[22], which is usually associated with silencing. In contrast,
another group found that the Paf1 complex was associated with
rDNA, and stimulates polymerase I elongation [23]: deletions in
Cdc73, Ctr9 or Paf1 resulted in polymerase I transcription
defects [24].
African trypanosomes multiply in the blood and tissue fluids
of mammals (as the ‘‘bloodstream form’’) and in Tsetse flies,
where the form found in the midgut is called the ‘‘procyclic
form’’. Trypanosomes offer an interesting model for the study of
RNA polymerase II transcription. Genes are arranged in
polycistronic transcription units, which are transcribed from
several start points [25] located in regions that are marked by
specific histone modifications [26], but not by any obvious
sequence conservation. Once initiation has occurred, elongation
can continue for over 150 kb [26]. Termination sites are
enriched in specific histone variants and are often followed by
tRNA genes [26]. Individual mRNAs are generated by
cotranscriptional processing – addition of a capped 39nt leader
at the 59 end by trans splicing, and 39 polyadenylation [27]. The
spliced leader genes, which encode the capped leader plus an
intron, are the only trypanosome polymerase II transcription
units that are monocistronic and have unique start sites. Once
mRNAs have been produced, their abundances are regulated by
differential degradation [28,29,30].
Proteins involved in trypanosome polymerase II transcription
apparatus differ in many ways from those of Opisthokonts. The
largest subunit of RNA polymerase II lacks the characteristic
heptapeptide repeats at the C-terminus, but that region is
nevertheless serine-rich, phosphorylated, and required for
transcription [31]. Various transcription factors have been
identified [32]. Some are identifiable (although often extremely
diverged) homologues of known transcription factors from other
eukaryotes, but others are not. For example, the spliced leader
promoter-binding complex has a Kinetoplastid-specific subunit
[33]; ENF, a protein that interacts with TfIIB, has various
motifs that are found in transcription factors, but has no clear
Opisthokont homologue [34]; and the trypanosome Mediator
complex resembles that of yeast in overall shape (as judged by
electron microscopy) but not in the protein primary structures
[35,36].
Trans splicing enables trypanosomes to produce protein-coding
mRNAs using RNA polymerase I. The genes encoding the
Variant Surface Glycoprotein (VSG) of the bloodstream forms,
together with several associated genes, are transcribed by
polymerase I from telomeric ‘‘expression sites’’, while the EP
and GPEET procyclins of the procyclic form, with a few
downstream ‘‘procyclin associated genes’’ (PAG) are transcribed
from chromosome-internal locations [37]. In both cases, the
polymerase I transcription is subject to developmental regulation,
which suppresses inappropriate expression; this is at lest partially
chromatin-mediated [38], but specific factors may also be involved
[36]. Transcription of the EP and GPEET procyclin genes is about
ten times more active in procyclic forms than in bloodstream forms
[36,39]; in addition, procyclin RNAs are very rapidly degraded in
bloodstream forms and stable in procyclic forms (reviewed in [29]).
In this paper, we investigated the function of CTR9 in
trypanosomes. We found evidence for interaction between
trypanosome CTR9, CDC73, and a putative homologue of
LEO1, and observed multiple effects on the transcriptome after
CTR9 depletion.
Methods
Trypanosomes and Plasmids
For RNAi, a TbCTR9-specific DNA fragment was cloned into
the vector p2T7TA blue [40] using the primers 59-
GGCACCCTGCAGAATATTCT-39 and 59-CGGAGGTAA-
ATTTGGCCGAG-39. The resulting plasmid was linearized with
Not I and transfected into bloodstream-form trypanosomes
expressing the tet repressor (pHD 1313) and T7 RNA polymerase
(pHD514). Transfectants were selected in 10 mg/ml hygromycin
and cloned by limiting dilution. For the growth curve shown,
RNAi was induced by adding tetracycline to the medium, at a
concentration of 1 mg/ml. Samples were taken after every
24 hours of RNAi induction for three days. In later experiments,
100 ng/ml tetracycline was used, with similar effects on cell
growth.
For expression of C-terminally myc-tagged CTR9, the gene was
amplified by standard PCR using the following oligonucleotides:
59- GGGCCCATGCAATATATATCGGAACCC–39 and 59-
GTTAACTATATTCCCATCATTAGCGGTGT–39. The frag-
ment was cloned into pHD1700 [41] at the Apa I and Hpa I sites
(pHD2244), and expression induced using 100 ng/ml tetracycline.
Expression of the C-terminally TAP-tagged version (IgG binding
domain and calmodulin binding peptide) was achieved similarly by
cloning into pHD 918 to give pHD2245 [42,43].
Protein Analysis
To determine the subcellular location of CTR9, approximately
5610
8 bloodstream cells expressing TAP or myc-tagged CTR9
were collected by centrifugation and analysed using NP-40 lysis
and centrifugation [44]). Proteins were analysed by Western
blotting, and detected by enhanced chemiluminescence (Amer-
sham, Braunschweig, Germany) according to the manufacturer’s
instructions. TAP- and myc-tagged CTR9 gave similar results.
For tandem affinity purification, expression of TAP-tagged
protein was induced for 24 h and about 1610
10 cells collected.
TAP purification was done as described by [45] and as modified
by [42]. Purified proteins were concentrated overnight by TCA,
then separated on a 10% uniform SDS-PAGE gel until all the dye
had entered the gel. The gel was stained using Colloidal
Coomassie. The section containing proteins was sliced into equal
pieces and analysed by LC-MS (ZMBH, DKFZ alliance).
RNA Analysis
RNASeq analysis was done using poly(A)+ mRNA extracted
24 h after tetracycline addition; in the culture used, growth
inhibition had not yet become apparent. Methods used were
exactly as previously described [30].
RNASeq data for the CTR9 RNAi mutant were compared to
those of 2 replicates of poly(A)+ mRNA from wild-type cells [30],
using DESeq [46]. Differentially expressed genes are those with a
p-adjusted-value ,0.05. Comparisons with other datasets were
done as follows. Transcription start and stop sites were annotated
manually, by scrutiny of histone modifications shown at
TritrypDB and published in [26]. The five ORFs that were
nearest to start or stop sites were designated as such in the Excel
tables, with the proximal ORF annotated as ‘‘–1’’ and the distal
one as ‘‘–5’’. Data for developmental regulation were extracted
from [47]. To determine whether genes are essential for growth,
we used published RNA interference sequencing data [48]. To
determine the fold effect of RNAi in the published screen, the
Trypanosome CTR9
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[48] were divided by the number of reads at day 0. ORFs showing
a decrease of at least 4-fold, coupled with statistical significance
(‘‘TRUE’’ judgement in the Table provided in [48]) were judged
to be essential for normal growth. Northern blots were done using
standard methods; reverse transcription and PCRs for RNA
detection were done as described in [30] using the primers listed in
Table S2.
Results
Trypanosome CTR9 is an Essential Protein which Co-
purifies with Homologues of Leo1 and Cdc73
The sequence encoded by Tb927.3.3220 was identified as a
Ctr9 homologue by reciprocal BLASTp analysis. Like other Ctr9s,
it contains multiple TPR repeats (Figure 1A); identities with
human, yeast and plant Ctr9s are 21%, 18% and 19%
respectively, with similarities spread throughout the sequence
(Figure S1). To identify interaction partners, we expressed a
version bearing a C-terminal tandem affinity purification (TAP)
tag in bloodstream T. brucei. The tagged CTR9 was subjected to
two steps of affinity purification and the proteins present in the
entire preparation were identified by mass spectrometry. Four
potential interaction partners were revealed (Table 1). Most
notably, there were potential homologues of Cdc73
(Tb927.11.10230) and Leo1 (Tb927.9.12900). There were also
two proteins of unknown function (Tb927.7.4030 and
Tb927.3.5070) which have no recognised functional domains
and no homologues in non-kinetoplastid eukaryotes; these have
not been further investigated. We did not check whether the
tagged CTR9 was functional, and tandem affinity purification is a
relatively stringent procedure, so additional interaction partners
might have been missed.
Trypanosome CDC73 shows 22%, 21%, and 25% identity with
the human, yeast and plant proteins, with more conservation
towards the C-terminus (Figure S2). Although only two peptides
were detected, this seems likely to be a genuine interaction partner.
In contrast, the overall identities for LEO1 are very low: 12%,
17% and 15% respectively; its identification relies exclusively on
the presence of a Leo1 domain (E value 1.6 e-5) between positions
217 and 257 (Figure 1B and Figure S3). We searched the
trypanosome genome for homologues of the remaining subunits
but were unable to find them. To look for an association between
CTR9 and RNA polymerase II, we precipitated the CTR9-TAP
and examined the precipitate for the presence of the largest
subunit: no association was seen (Figure S4).
Extrapolating from other systems, we expected to find CTR9 in
the nucleus. We therefore examined the protein by cell
fractionation. The control, XRND, was retained in the nucleus
while trypanothione reductase was found in the cytoplasmic
fraction (Figure 1C). In contrast, the 100 kDa C-terminally myc-
tagged CTR9 protein was found in both cytoplasm and nucleus
(Figure 1C). In repeat experiments with either myc- or TAP
tagged proteins, and using half as much tetracycline, the signals
were less strong but the protein was still found in both
compartments, with slightly more in the nucleus (not shown). It
is however possible that the localization of the tagged protein was
influenced by the presence of the tag.
Conservation of PAF Complex Subunits in Evolution
To investigate the evolutionary conservation of the PAF
complex, we searched eleven genomes representing all major
eukaryotic branches (except for Rhizaria), using the yeast, human
or trypanosome sequences as queries. We used standard NCBI
BLASTp settings without filters, and matches with poor coverage
were checked by reciprocal BLAST. Where results were negative,
we increased the sensitivity by searching individual genomes for
Ctr9, Cdc73 and Leo1, and for the Leo1 domain alone (Figure 1B).
Results (Table 2) suggest that the pentameric complex could be
present in plants, and in some, but not all, unikonts (Opisthokonts
and some Amoebozoa). Cdc73, Leo1 and Ctr9 were conserved
more widely in eukaryotic evolution, but no sequences resembling
any of the subunits were found in either Trichomonas or Giardia.
Evidently poor conservation could have compromised the
searches, but it does seem that Cdc73, Ctr9 and Leo1 are more
widely distributed than Paf1 and Rtf1.
Depletion of Ctr9 Results in Increased mRNA from the
Procyclin Loci
In a high-throughput RNAi screen CTR9, LEO1 and CDC73
were all found to be essential for normal growth of both
bloodstream and procyclic trypanosomes [48]. We indeed found
that RNAi targeting CTR9 in bloodstream forms resulted in
growth arrest after 1 day of tetracycline induction (Figure 1D). To
examine the reason for the growth arrest, we analysed the
poly(A)+transcriptome of the cells 24 h after tetracycline addition.
Trypanosome polymerase II transcription units contain
multiple open reading frames (ORFs). If CTR9 were required
for transcription processivity, we would expect that its depletion
would result in preferential depletion of mRNAs that are
towards the ends of transcription units. This was not seen -
increases and decreases were scattered almost randomly through
the transcription units (Table S1 and Figure 2A). Table 3 lists
the 47 ORFs that show the greatest increases in RNA
representation after CTR9 RNAi. The most dramatic change
was an increase in the expression of ORFs from the procyclin
transcription units (Table 3). Not only the EP and GPEET
procyclin genes, but also the downstream PAGs were affected
(Table 3 and Figure 2B). Of the remaining forty ORFs, more
than half are located near to rRNA loci, or at transcriptional
stop sites (Table 3 and Table S1). This phenomenon was,
however, restricted to relatively few chromosomal locations. To
find out whether RNA was generally increased near stop sites,
we examined 150 ORFs immediately upstream of points where
two polymerase II transcription units converge. For these, the
median change in transcript abundance was a 2-fold increase: 9
RNAs decreased more than 3-fold, and 48 increased more than
3 fold. Within 10 kb of convergence regions, the effects on
individual mRNAs were, however, by no means uniform: one
mRNA might go up while its neighbour went down. Figure 2A
shows the effect of the RNAi across two transcription units: in
one, there is a clear increase at the end, while at the other,
there is not. There was no obvious difference in organization
between termination points that showed increases and those that
didn’t.
We also looked to see whether CTR9 depletion changed
RNA processing patterns. Predominant splice acceptor sites
were mapped as before [30] for 4135 genes with at least 2 reads
per site for the CTR9 RNAi strain. About 37% of these sites
were found in the database of predominant sites used that were
determined previously on the basis of a collection of WT
RNASeq data [30]. Since a similar ratio was obtained when
only one wild-type sample was compared to the same database,
we concluded that CTR9 knockdown does not significantly affect
the use of splice acceptor sites.
To verify the RNASeq results, we probed Northern blots. The
increases in EP (Figure 2B), GPEET and PAG2 mRNAs (Figure 2C)
were confirmed, as was an increase from locus Tb11.01.4120, an
Trypanosome CTR9
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5-fold increase in expression by RNASeq (Figure 2C). Attempts to
confirm the up-regulation of some other mRNAs from polymerase
II transcription units were however unsuccessful, perhaps due to
low abundance (asterisks, Table 3). Some CTR9-RNAi-specific
reads concentrated in segments of non-coding regions or covered
only parts of ORFs; this has not been investigated further. Probing
of a Northern blot with a spliced leader probe, to detect all mature
mRNAs, did not reveal any global changes in mRNA abundance
(not shown).
The increase in EP and GPEET procyclin mRNAs seemed most
likely to be a transcriptional effect, since according to the RNASeq
results, the entire transcription units including the PAGs were
affected: effects on RNA processing or degradation would be
unlikely to affect each gene to such similar extents. To check this,
however, we assessed the degradation rate of the EP procyclin
mRNA. Results are shown in Figure 2D. In wild type cells the
mRNA has a half-life of less than10 minutes [49]. After CTR9
RNAi, the onset of EP mRNA degradation was reproducibly
delayed (Figure 2D), but the apparent 2-3-fold increase in half-life
was not, by itself, sufficient to explain the 9-fold increase in
mRNA. We therefore concluded that CTR9 RNAi probably
causes a failure of stage-specific transcriptional suppression at the
procyclin loci.
In trypanosomes, polyadenylation and trans splicing are coupled
[50,51]. To find effects of CTR9 depletion on RNA processing, we
thereforelookedforchangesintheuseofspliceacceptorsites,butno
significant difference wasfound (see Methods).
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Figure 1. Properties of CTR9 complex components. A. The locations of TPR repeats (SMART SM00028) in trypanosome (Tb), Saccharomyces
cerevisiae (Sc), human (Hs) and Arabidopsis thaliana (At) Ctr9 homologues. The maps are taken from the Interpro scan web site. Domains are shown as
thickened bars. B. The most conserved portion of the Leo1 domain. The alignment was made using the MegAlign portion of the DNAStar package; for
details see Figure S3. Identical amino acids are underlain in black and functionally conserved amino acids are underlain in grey. Dd: Dictyostelium
disoideum; Pi: Phytophthora infestans – Tp: Thalassiosira pseudonana; Tt: Tetrahymena thermophila; Ng: Naegleria gruberi. C. Myc-tagged CTR9
fractionates into both the nucleus and the cytoplasm. Cells expressing CTR9-myc were lysed with NP40, centrifuged, and the extracts subjected to
Western blotting using antibodies to myc (Santa Cruz), XRND (nuclear marker) and trypanothione reductase (cytoplasmic marker). T: total; N: nuclear
fraction; C: cytoplasmic fraction. D. Effect of RNAi against CTR9. Two separate bloodstream trypanosome lines (represented by different symbols)
were incubated with or without 100 ng/ml tetracycline. The starting cell density was 2610
5/ml and cultures were diluted to that level daily as
required.
doi:10.1371/journal.pone.0034256.g001
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that are Essential for Control of Gene Expression
We next examined mRNAs that were reduced after CTR9
RNAi. 349 were decreased at least ten-fold (Table S1). There
was no correlation between the effect of CTR9 depletion and
either developmental regulation or half-life (not shown). Even a
quick glance, however, was sufficient to explain why CTR9
RNAi was lethal: no fewer than 131 of the reduced mRNAs are
essential for normal growth. Some examples of essential genes
with at least 20-fold RNA decreases are shown in Table 4.
Multiple genes that encode proteins involved in gene expression
now had less than one copy of mRNA per cell: the largest RNA
polymerase II subunit and the second largest polymerase I
Table 1. Proteins that co-purified with CTR9-TAP.
Identified Proteins Accession Number No peptides
Paf complex subunits
CTR9 Tb927.3.3220 48
LEO1 Tb927.9.12900 6
CDC73 Tb927.11.10230 2
Novel proteins
hypothetical protein, conserved Tb927.7.4030 4
hypothetical protein, conserved Tb927.3.5070 4
Possible contaminants
calmodulin Tb927.11.13020 1
60S ribosomal protein L17 Tb927.11.4820 2
microtubule-associated protein 2 Tb10.v4.0052 4
polyubiquitin Tb927.11.9920 2
hypothetical protein, conserved Tb11.0840 2
ribosomal protein L3 Tb927.4.1790 2
60S ribosomal protein L12 Tb927.9.14000 4
glyceraldehyde 3-phosphate dehydrogenase, glycosomal Tb927.6.4280 6
glycerol kinase, glycosomal Tb927.9.12550 5
retrotransposon hot spot protein Tb11.0050 2
elongation factor 1-alpha,EF-1-alpha Tb927.10.2100 6
alpha tubulin Tb927.1.2340 20
beta tubulin Tb927.1.2330 23
heat shock protein 70 Tb927.11.11330 3
Proteins were denatured, separated by SDS-PAGE and the whole gel section containing proteins was analysed by mass spectrometry. The numbers of different peptides
detected are indicated. Possible contaminants are judged as such because of their appearance in other, unrelated purifications.
doi:10.1371/journal.pone.0034256.t001
Table 2. Putative homologues of the Paf complex subunits in various organisms.
Group/Kingdom Species Ctr9 Cdc73 Leo1 Paf1 Rtf1
Plantae Arabidopsis thaliana B5X0I6_ARATH B5X0I At3g22590 At5g61156 At1g79730 At1g61040
Opisthokonts Saccharomyces cerevsiae NP_014496.2 NP_013522.1 NP_014766.1 NP_009838.1 NP_011270.1
Opisthokonts Schizosaccharomyces pombe NP_594620.1 NP_595891.1 NP_596263.1 NP_593451.1 NP_595507.1
Opisthokonts Homo sapiens NP_055448.1| NP_078805.3 NP_620147.1 NP_061961.2 NP_055953.3
Amoebozoa Dictyostelium discoideum XP_642310.1 XP_644100.3 XP_637916.1 XP_645948.1 XP_637691.1
Amoebozoa Entamoeba histolytica XP_650475.1 XP_648719.1
Alveolata Tetrahymena thermophila EAR82060.1 (and
others)
EAR84002.1 EAR89919.2
Alveolata Plasmodium falciparum – XP_001351765.1 –
Stramenopila Thalassiosira pseudonana XP_002287483.1 XP_002287950.1 XP_002289477.1
Heterolobosea Naegleria gruberi XP_002679971.1 XP_002683436.1 XP_002670362.1
Euglenozoa Trypanosoma brucei Tb927.3.3220 Tb927.11.10230 Tb927.9.12900
No homologues were found in either Trichomonas or Giardia. More details are in Table S3.
doi:10.1371/journal.pone.0034256.t002
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nents of the mRNA degradation machinery, NOT1 and
XRNA; poly(A) binding protein 2 and some translation factors.
There were also other targets potentially involved in gene
expression: 7 RNA helicases, including DHH1; zinc finger
proteins ZC3H22, ZC3H28, ZC3H32, and ZC3H41, RNA-
binding domain proteins DRBD12 and DRBD17, and nearly all
of the pumilio domain proteins. mRNAs encoding at least 40
components of the cytoskeleton were reduced, as were four
involved in vesicular transport and eleven involved in DNA
replication and chromosome maintenance. Correspondingly, an
analysis for GO term enrichment showed highly significant
over-representation (P values of less than 10
–10) of gene
products in many categories related to nucleotide or nucleoside
binding or hydrolysis, as well as motor activity; cytoskeletal
categories were enriched with P values of less than 10
–5 (not
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Figure 2. Effects of CTR9 RNAi on the transcriptome. A. Effect of CTR9 RNAi on RNAseq representation, for poly(A)+ RNA, across two randomly-
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normalised to the 7SL RNA from the signal recognition particle (SRP). The half-life of EP mRNA is less than 8 min, as previously observed.
doi:10.1371/journal.pone.0034256.g002
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geneID rpkm CTR9/WT features
Procyclin locus
Tb927.6.520 EP3-2 procyclin 36.4 17 pol I
Tb927.6.510 GPEET2 procyclin 31.3 14 pol I
Tb927.10.10240 PAG1 2.5 48 pol I
Tb927.10.10220 PAG2 1.9 57 pol I
Tb927.6.530 PAG3 12.2 11 pol I
Tb927.10.10210 PAG4 2.6 31 pol I
Tb927.10.10230 PAG5 2.3 37 pol I
Near rRNA locus
Tb09.v2.0450 Unlikely ORF 2.0 17.0 rRNA locus
Tb927.2.1470 hypothetical conserved 3.6 10.0 0 kb, rRNA
Tb927.1.3750 hypothetical conserved 8.7 7.7 0 kb, rRNA
Tb927.3.3430 hypothetical conserved 7.4 7.6 0 kb, rRNA
Other
Tb927.5.4020 hypothetical 4.0 13** 3 kb
Tb927.8.6570 hypothetical conserved 3.4 10 0 kb
Tb927.8.510 hypothetical 1.1 21* 6 kb
Tb927.10.4390 hypothetical 3.6 7.8 3 kb
Tb927.10.4380 hypothetical 0.8 39* 2 kb, ESAG
Tb927.10.12270 hypothetical conserved 4.1 14* 1 kb
Tb927.10.1760 hypothetical 1.7 20* 0 kb
Tb927.11.9380 hypothetical 1.1 14* 0 kb
Tb927.1.2020 hypothetical 3.3 11 0 kb
Tb927.11.11990 hypothetical 1.3 11 0 kb
Tb927.8.480 phosphatase 26.6 9.8 0 kb
Tb927.2.3330 hypothetical 5.3 8.7 0 kb
Tb927.7.310 hypothetical conserved 8.9 8.1 0 kb
Tb927.10.9550 hypothetical 0.6 8.4 6 kb
Tb927.8.5930 hypothetical 0.3 9.4 stop/start
Tb927.3.650 hypothetical conserved 25.8 8.1 11 kb
Tb927.7.2430 Long poly(AT) tracts 0.2 16.9* repetitive
Tb927.11.4600 hypothetical 1.0 18.5 None
Tb927.10.10040 hypothetical 4.1 13.3 None
Tb927.3.2880 hypothetical conserved 7.6 11.7 None
Tb927.10.9030 hypothetical conserved 10.7 9.7 None
Tb927.3.3570 hypothetical conserved 10.8 9.1 None
Tb927.11.7260 hypothetical conserved 7.8 8.7 None
Tb927.6.4790 hypothetical conserved 33.9 8.2 None
Tb11.v4.0003 hypothetical 2.3 8.2 None
Tb07.26A24.210 hypothetical 4.7 7.8 None
Tb927.3.2370 hypothetical conserved 36.0 7.8 None
Tb927.10.260 hypothetical conserved 29.4 7.7 None
Tb927.10.7720 hypothetical conserved 35.7 7.6 None
Tb927.11.12330 hypothetical conserved 24.5 7.5 None
Tb927.2.2070 hypothetical 3.5 8.6
Tb927.6.4570 hypothetical conserved 13.8 8.6 start
One representative of each of the procyclin locus ORFs is shown, along with the 36 other ORFs showing the greatest increases in RNA after CTR9 RNAi. ‘‘rpkm’’ is the
reads per kilobase per million reads seen in poly(A)+RNA from normal (wild-type) cells, taken from [30]; the median for all ORFs is 30.6. ‘‘CTR9/WT’’ shows the fold
change in rpkm after RNAi (2 significant figures); **no signal was seen on a Northern blot using an ORF probe; *no RNA detected by reverse transcription and PCR
targeting the ORF. ‘‘Features’’ indicates transcription by polymerase I (pol I), and the distance of the 39 end of the locus mRNA from a convergent transcription stop area
– ‘‘0 kb’’ indicates that this is the last ORF in a transcription unit. ‘‘0 kb, rRNA’’ indicats that the ORF is the last on a pol II transcription unit, next to an rRNA locus read in
the opposite direction. ‘‘2 kb, ESAG’’ is a gene upstream of an ESAG. An rpkm of 20 corresponds to 1 mRNA per cell, which is difficult to detect by Northern blotting.
doi:10.1371/journal.pone.0034256.t003
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geneID gene description rpkm RNAi BS3 BS6
Cytoskeleton
Tb927.10.14470 IFT140 47.9 0.03 0.02 0.00
Tb927.10.2640 IFT81 114 0.04 0.00 0.00
Tb927.10.1170 IFT172 63.8 0.01 0.13 0.23
Tb927.5.3030 IFT122B 27.7 0.04 0.06 0.25
Tb927.6.3150 Hydin,flagellar component 19.2 0.04 0.05 0.01
Tb927.3.5310 paraflagellar rod protein 72.6 0.04 0.10 0.08
Tb927.11.15100 Paraflagellar rod Tb5.20 142 0.03 0.00 0.00
Tb927.11.3290 p166 23.9 0.04 0.45* 0.17
Tb927.4.870 dynein heavy chain 19.3 0.02 0.01 0.01
Tb927.11.3250 dynein heavy chain 64.5 0.01 0.01 0.02
Tb927.11.11220 dynein heavy chain 16.0 0.04 0.03 0.04
Tb927.11.8160 dynein heavy chain 24.9 0.02 0.06 0.04
Tb927.3.930 dynein heavy chain 63.3 0.03 0.03 0.05
Tb927.2.5270 dynein heavy chain 20.4 0.02 0.07 0.08
Tb927.11.2430 dynein heavy chain (DHC1b) 36.1 0.03 0.05 0.08
Tb927.10.5350 dynein heavy chain 26.9 0.03 0.27* 0.13
Tb927.8.3250 dynein heavy chain 28.1 0.02 0.06 0.18
Tb927.7.920 dynein heavy chain 27.3 0.04 0.18 0.21
Tb927.5.2090 kinesin 41.7 0.04 0.16 0.20
Gene expression & DNA replication
Tb927.10.1510 NOT1 36.0 0.01 0.18 0.08
Tb927.7.4900 5’-3’ exonuclease XRNA 14.8 0.04 0.15 0.17
Tb927.10.12660 RNA binding protein PUF2 7.0 0.04 0.15 0.00
Tb927.9.12510 DEAD/H RNA helicase 58.2 0.05 0.14 0.05
Tb927.3.2600 DEAD/H RNA helicase 53.8 0.04 0.12 0.16
Tb927.10.10340 SMC2 34.7 0.03 0.66* 0.14
Intracellular protein transport and other
Tb927.10.6050 clathrin heavy chain (CHC) 135 0.01 0.01 0.00
Tb927.10.2900 importin beta-1 subunit 38.6 0.03 0.10 0.02
Tb927.2.4230 NUP-1, nuclear pore 72.6 0.01 0.17 0.07
Tb927.10.2880 calcium channel protein 35.7 0.02 0.08 0.04
Tb927.11.1100 Clan CA cysteine peptidase 48.6 0.01 0.07 0.16
Tb927.7.2170 hypothetical protein 46.1 0.04 0.10 0.00
Tb927.7.3550 hypothetical protein 91.3 0.01 0.01 0.00
Tb927.8.4780 hypothetical protein 33.6 0.02 0.01 0.00
Tb927.8.2820 hypothetical protein 1801 0.01 0.31* 0.00
Tb927.9.7690 hypothetical protein 9.3 0.04 0.07 0.01
Tb927.10.870 hypothetical protein 32.4 0.02 0.08 0.02
Tb927.9.1750 hypothetical protein 11.0 0.02 0.05 0.02
Tb927.3.2050 hypothetical protein 20.3 0.03 0.92* 0.04
Tb927.10.15750 hypothetical protein 114 0.01 0.17 0.05
Tb927.1.4310 hypothetical protein 23.6 0.01 0.04 0.12
Tb927.9.13440 hypothetical protein 25.9 0.02 0.20 0.18
Tb927.7.3560 hypothetical protein 29.1 0.03 0.02 0.23*
Genes were selected by the following criteria: (a) mRNA decreased more than 20-fold by CTR9 RNAi and (b) A significant decrease of at least 5-fold in representation in
the RNAi library, using bloodstream forms either 3 or 6 days after tetracycline addition [48]. ‘‘rpkm’’ is the value for wild-type cells from RNASeq: an rpkm value of 20 is
equivalent to one mRNA per cell [30]. ‘‘RNAi’’ is the rpkm for CTR9 RNAi divided by that for wild-type. ‘‘BS3’’ indicates the representation of this gene in RITSeq analysis
in bloodstream forms, at day 3 after RNAi induction, divided by the representation without tetracycline; *not significant [48]. ‘‘BS6’’ is the same for 6 days of tetracycline.
doi:10.1371/journal.pone.0034256.t004
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deregulation of the procyclin loci: the mRNAs encoding ISWI
(Tb927.2.1810) and NLP1 (Tb927.10.5450), were repressed 8-
fold and 13-fold, respectively (Table S1 and Figure 2B). RNAi
targeting either of these genes deregulates silent expression sites,
the procyclin promoters and other silent regions [52,53].
Discussion
We have shown that trypanosome CTR9 co-purifies with
homologues of Leo1 and Cdc73 through two affinity purifica-
tion steps. It is therefore possible that trypanosomes possess a
‘‘PAF’’ complex of at least 3 subunits. The other two subunits,
Paf1 and Rtf1, appear to be missing, and a limited phylogenetic
analysis suggested that they might be restricted mainly to plants
and unikonts. There are two possible explanations. Either Paf1
and Rtf1 equivalents are absent in other eukaryotes, or proteins
with no evident sequence similarity are able to substitute
functionally for Rtf1 and Paf1. In support of the former
supposition, yeast can survive with just Ctr9, Leo1 and Cdc73:
deletion of either Rtf1 or Leo1 led to few obvious defects, and
although deletion of Paf1 had severe effects, these could be
partially abrogated by deletion of either Rtf1 or Leo1 [54]. For
the alternative, as noted in the Introduction, functional
equivalence in the absence of sequence similarity is already
known for some proteins involved in trypanosome transcription.
We did identify two additional candidate CTR9 binding
partners, Tb927.7.4030 and Tb927.3.5070, but have not
verified the association. In the published RNAi screen,
Tb927.7.4030 was found to be essential in bloodstream and
differentiating forms, and depletion of Tb927.3.5070 inhibited
growth [48].
In our affinity purification of tagged CTR9, we did not see co-
purification of any subunits of RNA polymerase II, or proteins
involved in chromatin modification or RNA processing. Such
interactions might not have survived the purification procedure, or
they could have been impaired by the presence of the tag.
However, it is also very possible that at least some of the
interactions that have been seen in other systems do not occur in
trypanosomes. For example, yeast [54,55] and human [8] RNA
polymerase II has been shown to coimmunoprecipitate with
various Paf complex components, and to copurify with the
complex, but the association of the human Paf complex with RNA
polymerase II depends on the presence of the PAF1 subunit [8].
Trypanosomes lack an obvious Paf1 homologue, and in the
human system, no interaction was seen between polymerase II and
purified CTR9, CDC73 or LEO1 [8]. Thus probably, no
interaction between the trypanosome CTR9/CDC73/LEO1 is
to be expected and indeed, none was found. Thus there is no
evidence that the trypanosome CTR9/CDC73/LEO1 complex is
involved in polymerase II elongation.
Depletion of CTR9 caused many changes in the transcriptome.
To find out whether these were simply a consequence of slowed
growth, we compared the most up-and down-regulated genes with
those previously detected, by microarray, after other growth-
inhibitory treatments: inhibition of glucose transport using
phloretin [56], and RNAi targeting RBP10 [57]. Of the 256
ORFs that showed greater than 3-fold decreases after CTR9
RNAi, only 4 decreased after phloretin (and 10 were more than
1.5-fold increased). Similarly, just 19 of theses same 256 ORFs
were 1.5-2-fold decreased after RBP10 RNAi while one increased
1.6-fold. For the 866 CTR9 RNAi up-regulated genes, only 10
(including EP and GPEET procyclin genes, but importantly, not
PAGs) were also at least 1.5-fold increased after RBP10 RNAi, and
8 after phloretin treatment. The CTR9 RNAi results also do not
resemble those seen after a lethal knock-down of ZC3H11 (D.
Droll, ZMBH, unpublished). This suggests that the transcriptome
changes after CTR9 RNAi were not simply caused by growth
inhibition.
By studying the time course of transcriptome changes after Paf1
depletion in yeast, Penheiter et al. [2] found that the first 16 RNAs
that were decreased included 11 essential genes; half of them were
involved in nucleolar structure and the processing of rRNA [2]. It
was therefore possible that many of the subsequent transcriptome
changes were secondary to rRNA processing defects. In trypano-
somes, we did not study the time course of effects, but certainly
within 24 h, CTR9 depletion had decreased so many mRNAs that
disentangling primary and secondary effects was not possible. In
particular, there were changes in the amounts of many mRNAs
encoding proteins that are required for mRNA synthesis and
control. First, mRNAs encoding components of RNA polymerases
I, II and III decreased to considerably less than one copy per cell:
this precludes in vivo analysis of specific roles of CTR9 in
polymerase II elongation. Next, the expression of NOT1 - a core
component of the major deadenylation complex - and of XRNA, a
59-39 exoribonuclease that is important for degradation of
relatively unstable mRNAs, was abolished. These two essential
proteins are required for mRNA degradation. Transcripts
encoding many RNA-binding proteins were also decreased;
knock-on effects could have occurred if proteins that regulate
mRNA degradation were lost while mRNA degradation pathways
were still active. Finally, the increase that we observed in
polymerase-I-transcribed mRNAs was most likely due to a
reduction in chromatin silencing, consequent to the disappearance
of ISWI and NLP1.
C-terminally tagged CTR9 was found in both the cytoplasm
and the nucleus. Although the tag might have influenced the
result, the localisation is in accordance with the PSORTII
prediction: the localization percentages of neighbours were 22%
nuclear and 61% cytoplasmic for trypanosome CTR9. In contrast,
yeast and mammalian proteins yielded 90%, and Drosophila 48%,
nuclear scores. It is therefore possible that trypanosome CTR9
functions in both compartments, or is regulated by nucleo-
cytoplasmic shuttling.
Overall, our results suggest that trypanosome CTR9 may
function as a complex with CDC73, LEO1, and perhaps other
proteins. The complex components clearly have essential func-
tions, most likely in gene expression in either the cytoplasm, the
nucleus, or both, but the precise natures of these functions remain
unclear.
Supporting Information
Figure S1 Alignment of Ctr9 homologues, made using
MegAlign (DNAStar). Residues that are identical to the
majority consensus are highlighted in black, and residues that
are within the consensus group (consensus #1) in grey. Groups are
f-hydrophobic; p-polar, a-acidic, b-basic. Organisms are: Tb- T.
brucei, At- Arabidopsis thaliana, NP_178674.6; Dd- Dictyostelium
discoideum XP_642310; Eh- Entamoeba histolytica EAL45089; Hs-
Homo sapiens NP_055448; Ng- Naegleria gruberi XP_002679971; Sc-
Saccharomyces cerevisiae Ctr9; Sp- Schizosaccharomyces pombe
CAA15833.
(PDF)
Figure S2 Alignment of Cdc73 homologues, made using
MegAlign (DNAStar). Details as for Figure S1. Organisms are:
Tb- T. brucei, Sc- Saccharomyces cerevisiae; Sp- Schizosaccharomyces pombe
NP_595891.1; Hs- Homo sapiens NP_078805.3; Dd- Dictyostelium
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Plasmodium falciparum XP_001351765.1; Tt- Tetrahymena thermophila
EAR84002.1; Pi- Phytophthora infestans XP_002903756.1; Eh-
Entamoeba histolytica XP_648719.1; Tv- Trichomonas vaginalis
XP_001310227.1; Tp- Thalassosira pseudonana XP_002287950.1.
(PDF)
Figure S3 Alignment of Leo1 homologues, made using
MegAlign (DNAStar). Details as for Figure S1. Organisms are:
Tb- T. brucei, At- Arabidopsis thaliana; Dd- Dictyostelium discoideum
XP_637916.1; Tp- Thalassiosira pseudonana XP_002289477.1; Hs-
Homo sapiens NP_620147.1; Sc- Saccharomyces cerevisiae Leo1; Ng-
Naegleria gruberi XP_002677260.1; Tt- Tetrahymena thermophila
EAR92336.1; Pi-Phytophthora infestans XP_002903832.1
(PDF)
Figure S4 TbCTR9-RPB1 co-immunoprecipitation.
Method: Bloodstream-form trypanosomes cell lines expressing
TAP-tagged TbCTR9 were used (lanes 5–8), with cells expressing
TAP-tag alone as control (lanes 1–4). Protein expression was
induced for 24 hrs. 1.5610
8 cells were collected by centrifugation
and washed once with 16PBS. Cells were lysed in 500 ml breakage
buffer as previously described [42,45]. The concentration of NaCl
was then adjusted to 150 mM and cell debris was removed by
centrifugation (4uC) at 13000 rpm in the microfuge for 30 min-
utes. IgG beads were washed as previously described then clarified
cell lysates was added prior to incubation for 2 hrs at 4uCi na
microfuge tube rotating at 15 rpm. The unbound fraction was
collected by centrifugation. The beads were washed 46 with
IPP150 buffer [42,45] and the protein recovered by boiling the
beads in 16Laemmli lysis buffer. Proteins were separated on an
8% SDS-PAGE gel and transferred overnight to nitrocellulose
membranes at 30 V. Protein detection by ECL kit (GE
Healthcare) was done using (1:1000) anti-RPB1 (unpublished, a
kind gift from Gu ¨nzl laboratory); (1:2000) anti- PAP (peroxidase–
antiperoxidase complex; for Protein A detection (Sigma)) for TAP.
The loading was equivalent to 5610
6 cells for lysate (lanes 1,8) and
unbound (Lanes 2,7) fractions; For wash 4 (TCA-concentrated,
lanes 3 and 6) and the bead-bound fraction (lanes 4 and 5), the
whole preparation was loaded. Results: A good signal of the bound
CTR9-TAP protein was detected (lane 5) but there was no
detectable RBP1 signal (lane 5). Similar results were obtained by
immunoprecipiation of CTR9-myc (not shown).
(PDF)
Table S1 Effects of CTR9 on the transcriptome. The first
Table is all genes, with ESAGs, VSGs and pseudogenes excluded.
The second Table (sheet 2) includes only the ‘‘unique genes’’ of
Siegel et al; these are single copy genes or, for repeated genes, a
single representative of the gene family. Columns are as follows: A.
TritrypDB accession number, v5; B. TritrypDB accession number,
v5, but with additional zeros to give each gene ID within a
chromosome the same number of digits. This enables a simple sort
to arrange the genes in the order in which they appear on the
chromosome. C. Annotation in TritrypDB; D. RNASeq results for
poly(A)+RNA from cells after 1 day of RNAi targeting CTR9.
The reads per kilobase per million reads for the ORF, divided by
the ORF copy number (see Manful et al., 2011 for how the copy
number was calculated). E. RNASeq results for poly(A)+ RNA
from normal cells (see Manful et al., 2011). F. RNASeq results (D)
divided by (E). G. Half-life for total RNA (taken from Manful et
al., 2011). H. Developmental regulation, taken from Siegel et al.,
2010. I. Position of the ORF near a start or stop site, as judged by
the enrichment of modified histones as described in Siegel et al.,
2009, and displayed on the TritrypDB web site. J. Details of the
relative position of the ORF near a start or stop site: the number
indicates whether the ORF was the first, second, third etc. relative
to the transcription break. K. Nature of start/stop - convergent
stops, divergent starts, or stops immediately followed by another
start. L. Other notes - gene position near telomeres, pol I
transcription, etc. M. Neighbouring locus, if transcribed by pol I or
pol III. Only strongly-regulated genes are annotated. N. P-value
for regulation (see Methods). Centromeres are from Genome Biol.
2007; 8(3): R37.
(XLSX)
Table S2 Oligonucleotides used to amplify cDNAs, with
comments.
(XLS)
Table S3 Details of BLAST search results. Standard
settings were used. Culumns C and D: For Arabidopsis thaliana,
the single genome was searched. For all other genomes, the search
was done using eleven genomes selected from the NCBI whole
genomes database (http://www.ncbi.nlm.nih.gov/sutils/genom_
table.cgi). The E values are therefore not comparable with those
for Arabidopsis since a much larger database was searched.
Columns E and F: Individual genes were blasted back against the
S. cerevisiae or H. sapiens databases only. E values are given only
if the relevant protein sequence was the best match.
(XLSX)
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